Companies: 10,795·Total market cap: $144.5T
Beam Therapeutics Inc.

Beam Therapeutics Inc.

BEAMNASDAQHealthcare● Active
$29.40
$-3.44(-10.48%)
Market Cap$3.0B
P/E Ratio
52W High$36.44
52W Low$15.6

Beam Therapeutics Inc.(BEAM)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

beam · 股价预测 · 27 位分析师(近3月)· FMP

分析师评级与共识

基于过去 3 个月内 27 位华尔街分析师

SellBuy

Buy

27 位分析师

共识

评级分布

Strong Buy
0
Buy
18
Hold
8
Sell
1
Strong Sell
0
合计: 27 · 买入占比: 66.7%

12 个月目标价

High

$80.00

Consensus

$48.00

+63.3% upside

Low

$26.00

Median: $40 · Last Close: $29.40

Beam Therapeutics Inc.(BEAM)的分析师共识为 Buy,基于过去 3 个月内 27 位华尔街分析师的评级。BEAM 的 12 个月平均目标价为 $48.00,相对当前价 $29.40 代表 +63.3% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

Historical priceConsensus $48 (63.3%)

Consensus Target

$48.00

63.3% upside

High Target

$80

172.1%

Low Target

$26

-11.6%

Current Price

$29.40

as of today

Based on analyst price targets, the BEAM stock price prediction for the next 12 months ranges from $26 to $80. The consensus BEAM price forecast of $48.00 implies 63.3% upside from the current price of $29.40.

短期股价预测

预测引擎就绪后将提供短期股价预测。

长期股价预测

预测引擎就绪后将提供长期股价预测。

基于技术分析的股价预测

预测引擎就绪后将提供技术分析。

最新分析师评级与调整

Filter:

Wall Street analysts have recently issued updated ratings on Beam Therapeutics Inc. (BEAM) stock. Of the recent 0 rating actions, 0 were upgrades and 0 were downgrades. 27 analysts currently cover BEAM.

分析师推荐趋势

BEAM analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

Revenue Next Year

EPS This Year

EPS Next Year

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast BEAM EPS of $ for the current fiscal year, based on estimates from 0 analysts. The BEAM revenue forecast is for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

BEAM 股价预测由两类独立数据源支撑:来自 27 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。BEAM 的共识目标价为 $48.00(+63.3% 上行空间),分析师共识为 Buy。

Beam Therapeutics Inc. 在 NASDAQ 上市,代码 BEAM。BEAM 在 2027 年的整体展望偏积极,在覆盖分析师中约 67% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

BEAM 预测 · 8 个问题

根据 27 位华尔街分析师,BEAM 的 12 个月平均目标价为 $48.00,最高 $80.00、最低 $26.00。若有图表,中位目标价可在上方查看。相对当前价 $29.40,隐含约 +63.3% 的上行空间。

BEAM 目标价BEAM 分析师目标价BEAM 12个月目标价目标价 BEAM

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.